Home World News Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation in... World News Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation in Patients with TP53 Y220C-mutated Solid Tumours By Ogkologos - March 2, 2026 466 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PYNNACLE study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR EMA Recommends Extension of Therapeutic Indications for Ibrutinib July 15, 2022 Study Links Mental Health Treatment to Improved Cancer Survival July 10, 2020 Mom Unknowingly Has Cancer For 3 Years After Doctor Keeps Telling... March 21, 2019 Mark Hoppus Of Blink-182 Announces He’s Cancer-Free October 8, 2021 Load more HOT NEWS ASCO20 Virtual Research Round Up Podcast: Breast Cancer, Sarcoma, and Supportive... Researchers Find a Way to Prevent Cancer Cells from Taking in... Telehealth-Based Cancer Care Surged during COVID. Will It Continue? Why Keeping Up With Your Cancer Screening Is So Important
